Rhinocort Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Rhinocort General Information
Description
Rights to Rhinocort Aqua. The asset is a nasal spray indicated for allergic and non-allergic rhinitis, inflammation of the inside of the nose and for the treatment of nasal polyps like swelling of the nasal lining.
Contact Information
Website
www.rhinocort.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Primary Office
- Cambridge
- England, United Kingdom
Rhinocort Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Rhinocort Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|